Literature DB >> 8853217

Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change.

P Roullet1, A Mele, M Ammassari-Teule.   

Abstract

Injections of glutamatergic NMDA as well as dopaminergic antagonists produce selective place- but not cue-learning deficits in associative spatial tasks. The present work was aimed at examining if the blockade of NMDA and dopaminergic receptors interferes with the encoding of spatial information in a non-associative task specifically designed for rodents. CD1 mice injected with MK-801 (0.1 and 0.25 mg/kg), haloperidol (0.04 and 0.08 mg/kg), a combination of the lower doses of each drug (haloperidol: 0.04 mg/kg and MK-801: 0.1 mg/kg) or saline were placed in an open field containing five objects and their reactivity to the displacement (spatial change) or the substitution (non-spatial change) of some of these objects was examined. The results show that saline-injected mice reacted to spatial as to non-spatial change by increasing the time spent exploring the displaced objects or the substituted one. Both doses of MK-801 prevented mice from detecting spatial change but did not affect their reactivity to the novel object. Both doses of haloperidol abolished the reactivity of mice to spatial change but the higher dose of the drug also altered the reaction to non-spatial change. Taken together, the present results indicate that the blockade of dopaminergic or glutamatergic NMDA receptors abolishes the detection of spatial novelty. The well-documented impairing effects of haloperidol and MK-801 on spatial learning may, therefore, be the consequence of a drug-induced inability in forming and/or updating spatial representations. The effects of haloperidol was, however, less specific than that of MK-801, since haloperidol always modified activity together with the response to spatial change and, at the higher dose, abolished the detection of both spatial and non-spatial change. Finally, haloperidol pretreatment was found to enhance the effect of MK-801 thus suggesting a possible interaction between the two systems in modulating these behavioral responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853217     DOI: 10.1007/bf02246411

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

Review 1.  Behavioural pharmacology of glutamate in the basal ganglia.

Authors:  W J Schmidt; M Bubser; W Hauber
Journal:  J Neural Transm Suppl       Date:  1992

2.  Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.

Authors:  A Vezzani; R Serafini; M A Stasi; S Caccia; I Conti; R V Tridico; R Samanin
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

3.  The role of the hippocampal-nucleus accumbens pathway in radial-arm maze performance.

Authors:  G B Schacter; C R Yang; N K Innis; G J Mogenson
Journal:  Brain Res       Date:  1989-08-14       Impact factor: 3.252

4.  The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli.

Authors:  H Dai; R J Carey
Journal:  Behav Brain Res       Date:  1994-06-30       Impact factor: 3.332

5.  The development of food search behavior by rats: the effects of hippocampal damage and haloperidol.

Authors:  R D Oades; R L Isaacson
Journal:  Behav Biol       Date:  1978-11

6.  Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat.

Authors:  C.S. Maldonado-Irizarry; A.E. Kelley
Journal:  Behav Pharmacol       Date:  1995-08       Impact factor: 2.293

7.  Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.

Authors:  R Dall'Olio; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity.

Authors:  H E Criswell; D J Knapp; D H Overstreet; G R Breese
Journal:  Alcohol Clin Exp Res       Date:  1994-06       Impact factor: 3.455

9.  Spatial memory and N-methyl-D-aspartate receptor antagonists APV and MK-801: memory impairments depend on familiarity with the environment, drug dose, and training duration.

Authors:  Z Caramanos; M L Shapiro
Journal:  Behav Neurosci       Date:  1994-02       Impact factor: 1.912

10.  Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat.

Authors:  J A Gorter; J P de Bruin
Journal:  Brain Res       Date:  1992-05-15       Impact factor: 3.252

View more
  7 in total

1.  NMDA and AMPA antagonist infusions into the ventral striatum impair different steps of spatial information processing in a nonassociative task in mice.

Authors:  P Roullet; F Sargolini; A Oliverio; A Mele
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

2.  Modeling early cortical serotonergic deficits in autism.

Authors:  Carolyn B Boylan; Mary E Blue; Christine F Hohmann
Journal:  Behav Brain Res       Date:  2006-10-10       Impact factor: 3.332

3.  Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.

Authors:  Brandon K Harvey; Jenny Chou; Hui Shen; Barry J Hoffer; Yun Wang
Journal:  Neurotoxicology       Date:  2009-02-13       Impact factor: 4.294

4.  Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.

Authors:  Viviane Labrie; Tatiana Lipina; John C Roder
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

5.  Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.

Authors:  V Labrie; W Wang; S W Barger; G B Baker; J C Roder
Journal:  Genes Brain Behav       Date:  2009-08-05       Impact factor: 3.449

6.  Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.

Authors:  Viviane Labrie; Ryutaro Fukumura; Anjali Rastogi; Laura J Fick; Wei Wang; Paul C Boutros; James L Kennedy; Mawahib O Semeralul; Frankie H Lee; Glen B Baker; Denise D Belsham; Steven W Barger; Yoichi Gondo; Albert H C Wong; John C Roder
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

7.  Impaired spatial memory after ketamine administration in chronic low doses.

Authors:  C Venâncio; A Magalhães; L Antunes; T Summavielle
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.